Clinical Trial Details

PRO2TECT-CONVERSION – Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral AKB-6548 for the Maintenece Treatment of Anemia in Subjects with Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)

Principal Investigator(s)

Location

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.